

| カタログ番号 | DF879048 |
|---|---|
| 説明 |
Infliximab ELISA Kit (DF879048) — Quantitative sandwich ELISA for Infliximab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| サンプルタイプ | Plasma, Serum |
| 感度 | 0.156 μg/ml |
| レンジ | 0.31-5 μg/mL |
| アクセッション番号 | CAS: 170277-31-3 |
| アプリケーション | ELISA |
| 検出方法 | Colorimetric |
| アッセイタイプ | Quantitative |
| 回収率 | 80-120% |
| 発送 | 2-8 ℃ |
| 安定性と保存 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| 仕様 | Infliximab |
| 別名 | TA-650, cA2, 170277-31-3 |
| 背景 | Infliximab is a chimeric monoclonal antibody and used to treat auto- immune disorders. Infliximab reduces the amount of active human tumour necrosis factor alpha (hTNFa) in the body by binding to it and preventing it from signaling the receptors for TNFa on the surface of various cell types. TNFa is one of the key cytokines that triggers and sustains the inflammatory reactions. Infliximab is used for the treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis. |
| 注意事項 | For Research Use Only. |
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206

中文
English
한국어
日本語
Español
Français
Русский